Portopulmonary hypertension practice patterns after liver transplantation
Liver Transplantation · 2023-04 · 29 (4) · 365-376
DOI: 10.1002/lt.26575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver Transplantation, online erschienen am 05.09.2022. Verfasst von Arun Jose und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, and Sleep Medicine , University of Cincinnati , Cincinnati , Ohio , USA. Hauptthemen laut MEDLINE: Liver Transplantation, Pulmonary Arterial Hypertension, Hypertension, Pulmonary, Hypertension, Portal. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Portopulmonary hypertension (POPH) is a type of pulmonary arterial hypertension occurring exclusively in those with portal hypertensive liver disease. Liver transplantation (LT) can significantly improve outcomes. Current guidelines counsel against immediate adjustments to targeted therapy after LT and suggest routine echocardiography as sufficiently informative to guide therapeutic adjustments. Current practice patterns for adjusting targeted therapy after LT in POPH, and how they compare with guidelines, are not well established. To answer this question, we performed an institutional review board–approved, cross‐sectional mixed‐methods survey‐based study of US POPH providers. Anonymized requests to complete the survey were sent through professional networks between January 20, 2022, and April 20, 2022. Responses were compared between cardiologists and pulmonologists using Fisher's exact tests, at a significance of 0.05. A total of 85 POPH physicians were included in the final analysis (66% pulmonologists and 34% cardiologists). Following LT, the majority of respondents routinely used a combination of standard cardiopulmonary assessment modalities to guide adjustment of targeted therapy following LT. Most respondents (69%) started by adjusting parenteral prostacyclins with small titrations and frequent reassessments within 3 months of LT, but some (19.7%) adjusted targeted therapy immediately after LT. Our results showed that the majority of respondents favored serial integrated cardiopulmonary testing (including routine right heart catheterization) to guide the adjustment of targeted therapy in POPH after LT, and almost one‐fifth of respondents weaned therapy immediately after LT. Our study demonstrates heterogeneity in POPH practice patterns after LT, highlights differences between current practice patterns and the most recent guidelines, emphasizes the need for additional research, and supports a team‐based approach to standardize care for these high‐risk patients and optimize post‐LT outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, and Sleep Medicine , University of Cincinnati , Cincinnati , Ohio , USA.
- Department of Surgery , University of Cincinnati , Cincinnati , Ohio , USA.
ORCID-Profile: Arun Jose, Elizabeth J Kopras, Shimul A Shah, Jean M Elwing
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Jose, A., Kopras, E. J., Shah, S. A., & Elwing, J. M. (2023). Portopulmonary hypertension practice patterns after liver transplantation. Liver Transplantation, 29(4), 365-376. https://doi.org/10.1002/lt.26575
Vancouver
Jose A, Kopras EJ, Shah SA, Elwing JM. Portopulmonary hypertension practice patterns after liver transplantation. Liver Transplantation. 2023;29(4):365-376. doi:10.1002/lt.26575
BibTeX
@article{Jose2023,
author = {Jose, Arun and Kopras, Elizabeth J and Shah, Shimul A and Elwing, Jean M},
title = {Portopulmonary hypertension practice patterns after liver transplantation},
journal = {Liver Transplantation},
year = {2023},
volume = {29},
number = {4},
pages = {365--376},
doi = {10.1002/lt.26575}
}
EUVIMED